Curis | CRIS - Ebit


Curis reported $-7.88M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Alaunos Therapeutics USD -1.01M 175K Mar/2026
Amgen USD 3.83B 130M Mar/2026
AstraZeneca USD 7.11B 4.14B Mar/2026
Bayer EUR 3.53B 2.42B Mar/2026
Bristol-Myers Squibb USD 3.56B 90M Mar/2026
CSL USD 2.64B 116M Dec/2025
Curis USD -7.88M 4.31M Dec/2025
Eli Lilly USD 9.78B 792M Mar/2026
Exelixis USD 251.34M 15.43M Mar/2026
Gilead Sciences USD 2.68B 284M Mar/2026
GlaxoSmithKline GBP 2.29B 856M Mar/2026
Incyte USD 344.17M 39.71M Mar/2026
Merck USD -1.88B 8.12B Mar/2026
Novartis USD 4.18B 118M Mar/2026
Pfizer USD 4.99B 340M Mar/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sanofi EUR 1.94B 239M Mar/2026
Takeda JPY -13.62B 271.11B Mar/2026
TG Therapeutics USD 34.8M 15.7M Mar/2026
Verastem USD -41.48M 4.44M Dec/2025